SE0200598D0 - Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences - Google Patents

Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences

Info

Publication number
SE0200598D0
SE0200598D0 SE0200598A SE0200598A SE0200598D0 SE 0200598 D0 SE0200598 D0 SE 0200598D0 SE 0200598 A SE0200598 A SE 0200598A SE 0200598 A SE0200598 A SE 0200598A SE 0200598 D0 SE0200598 D0 SE 0200598D0
Authority
SE
Sweden
Prior art keywords
lactoferrin
treatment
human
hypoxic
states
Prior art date
Application number
SE0200598A
Other languages
English (en)
Inventor
Klas Norrby
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Priority to SE0200598A priority Critical patent/SE0200598D0/sv
Publication of SE0200598D0 publication Critical patent/SE0200598D0/sv
Priority to US10/505,569 priority patent/US20050222007A1/en
Priority to EP03743090A priority patent/EP1478387A1/en
Priority to AU2003210086A priority patent/AU2003210086A1/en
Priority to PCT/SE2003/000329 priority patent/WO2003072129A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
SE0200598A 2002-02-27 2002-02-27 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences SE0200598D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0200598A SE0200598D0 (sv) 2002-02-27 2002-02-27 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
US10/505,569 US20050222007A1 (en) 2002-02-27 2003-02-27 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
EP03743090A EP1478387A1 (en) 2002-02-27 2003-02-27 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
AU2003210086A AU2003210086A1 (en) 2002-02-27 2003-02-27 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
PCT/SE2003/000329 WO2003072129A1 (en) 2002-02-27 2003-02-27 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200598A SE0200598D0 (sv) 2002-02-27 2002-02-27 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences

Publications (1)

Publication Number Publication Date
SE0200598D0 true SE0200598D0 (sv) 2002-02-27

Family

ID=20287109

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200598A SE0200598D0 (sv) 2002-02-27 2002-02-27 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences

Country Status (5)

Country Link
US (1) US20050222007A1 (sv)
EP (1) EP1478387A1 (sv)
AU (1) AU2003210086A1 (sv)
SE (1) SE0200598D0 (sv)
WO (1) WO2003072129A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005307199B2 (en) * 2004-11-19 2011-04-28 Fonterra Co-Operative Group Limited Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
DE102009049702A1 (de) * 2009-10-18 2011-04-21 Vczs Venture Capital Zentralschweiz Ag Verwendung von Lactoferrin und Lactoferrin enthaltende Zusammensetzungen
CN111879949B (zh) * 2020-08-05 2021-11-09 中国科学院昆明动物研究所 检测或调控乳铁蛋白表达量的物质在制备预防和/或治疗心脑血管疾病药物或试剂盒的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07278011A (ja) * 1994-04-01 1995-10-24 Morinaga Milk Ind Co Ltd 狭心症治療剤
US5712247A (en) * 1995-02-21 1998-01-27 University Of North Carolina Use of lactoferrin to modulate and/or neutralize heparin activity
JP3888707B2 (ja) * 1996-01-22 2007-03-07 森永乳業株式会社 血管新生病治療剤
JP2002515893A (ja) * 1997-02-03 2002-05-28 ファーミング インテレクチュアル プロパティ ビーブイ ヒトラクトフェリンおよびその改変体の有用な特性
FR2762850B1 (fr) * 1997-05-02 2000-02-11 Biocem Lactoferrines recombinantes, leurs procedes de production par les plantes ainsi que leurs utilisations
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US6426362B1 (en) * 1999-10-08 2002-07-30 Galileo Laboratories, Inc. Formulations of tocopherols and methods of making and using them

Also Published As

Publication number Publication date
EP1478387A1 (en) 2004-11-24
AU2003210086A1 (en) 2003-09-09
US20050222007A1 (en) 2005-10-06
WO2003072129A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
JP2002532432A5 (sv)
RU2001128504A (ru) Композиции для стимулирования роста
ATE432289T1 (de) Glp-1 und behandlungsmethode für diabetes
DE69933208D1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
NO20015584L (no) Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
RU99120189A (ru) Препараты для лечения метаболического синдрома, содержащие гормон роста человека в комбинации с ингибитором синтеза кортзола
Gileva et al. Hirudotherapy
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
DE60115432D1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
IL194500A (en) A peptide substance capable of increasing capillary resistance and pharmacological preparation containing the above
AR048806A1 (es) Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio
JP2002530353A5 (sv)
DE60313356D1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
RU2005131578A (ru) Аплидин для лечения множественной миеломы
SE0200598D0 (sv) Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
HUP0204324A2 (en) Use of fsh for preparation of pharmaceutical composition suitable for treating infertility
CA2516458A1 (en) Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
ES2182840T3 (es) Factor xiii para el tratamiento de heridas de la piel.
ATE331523T1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
ATE454397T1 (de) Den blutzuckerspiegel bei diabetes mellitus regulierendes tetrapeptid
JP2002529515A5 (sv)